IMV Inc.  Banner Image

IMV Inc.

  • Ticker IMV
    Exchange TSX More
  • Industry Biotechnology More
  • Sector Healthcare More
IMV Inc.  Logo Image
  • 51-200 Employees
  • Based in Dartmouth, Nova Scotia
IMV Inc. is a clinical-stage immuno-oncology company dedicated to making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. IMV's proprietary drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system. Lead product candidateMore DPX-Survivac is currently being evaluated in several clinical trials in advanced ovarian cancer in combination with other innovative immunotherapy agents.
4.7 / 5.0 (98)

IMV Inc. reports have an aggregate usefulness score of 4.7 based on 98 reviews.

IMV Inc.

Most Recent Annual Report

IMV Inc.
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

IMV Inc.  Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!